GENE ONLINE|News &
Opinion
Blog

The Rise of Asia as a Destination of Biotech Investment and Opportunity

by Sangeeta Chakraborty
Share To
Dr. Monica He, Senior Director, International Affairs, BIO moderated the session “Asian opportunities and collaboration” that featured distinguished panelists discussing the collaborative opportunities and business models in the pharma and biotech sector of Asia while also touching upon the impact of the pandemic on the future.

GO Prime with only $1.49 now

LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
Scroll to Top